MLLT10 and acute leukemia: The 2022 WHO classification further mentioned that genomic findings such as PICALM::MLLT10 fusions are enriched in mixed‐phenotype acute leukemias (MPALs), which belong to acute leukemias of ambiguous lineage (ALAL) but need more data [5, 6].